News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive June 1, 2017 Deciphera Pharmaceuticals Announces $52 Million Series C Financing to Advance Novel Clinical-stage Oncology Pipeline Archive May 18, 2017 Deciphera Pharmaceuticals to Report Phase 1 Clinical Study Results with DCC-2618 at the 2017 American Society of Clinical Oncology Annual Meeting Archive April 3, 2017 Translational Research Results Confirm The Broad Activity of DCC-2618 in GIST Patients With Difficult to Treat Drug Resistant KIT Mutations Archive March 16, 2017 Deciphera Pharmaceuticals to Present at 27th Annual Oppenheimer Healthcare Conference Archive March 7, 2017 Deciphera Pharmaceuticals to Report Translational Research Findings with DCC-2618 at the 2017 American Association for Cancer Research (AACR) Annual Meeting Archive March 6, 2017 Deciphera Pharmaceuticals Initiates a Phase 1 Clinical Trial of DCC-3014 Archive January 3, 2017 Deciphera Pharmaceuticals to Present at 35th Annual J.P. Morgan Healthcare Conference Archive December 1, 2016 Deciphera Pharmaceuticals Reports Encouraging Clinical Results with DCC-2618 in Genetically-defined Cancers with Drug Resistant Mutations Archive October 31, 2016 Deciphera Pharmaceuticals to Present Clinical Data on Tumor Targeted Advanced Kinase Inhibitors at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Archive October 6, 2016 Deciphera Pharmaceuticals Appoints Christopher J. Morl, M.B.A. as Chief Business Officer
Archive June 1, 2017 Deciphera Pharmaceuticals Announces $52 Million Series C Financing to Advance Novel Clinical-stage Oncology Pipeline
Archive May 18, 2017 Deciphera Pharmaceuticals to Report Phase 1 Clinical Study Results with DCC-2618 at the 2017 American Society of Clinical Oncology Annual Meeting
Archive April 3, 2017 Translational Research Results Confirm The Broad Activity of DCC-2618 in GIST Patients With Difficult to Treat Drug Resistant KIT Mutations
Archive March 16, 2017 Deciphera Pharmaceuticals to Present at 27th Annual Oppenheimer Healthcare Conference
Archive March 7, 2017 Deciphera Pharmaceuticals to Report Translational Research Findings with DCC-2618 at the 2017 American Association for Cancer Research (AACR) Annual Meeting
Archive January 3, 2017 Deciphera Pharmaceuticals to Present at 35th Annual J.P. Morgan Healthcare Conference
Archive December 1, 2016 Deciphera Pharmaceuticals Reports Encouraging Clinical Results with DCC-2618 in Genetically-defined Cancers with Drug Resistant Mutations
Archive October 31, 2016 Deciphera Pharmaceuticals to Present Clinical Data on Tumor Targeted Advanced Kinase Inhibitors at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Archive October 6, 2016 Deciphera Pharmaceuticals Appoints Christopher J. Morl, M.B.A. as Chief Business Officer
